B2M and carcinoma: Assessment of genes most upregulated within NHS–rmIL-12–treated carcinoma revealed increased expression of IFN-γ–responsive genes involved in antigen presentation, including B2m, H2-A, Cd74, the immune checkpoint Cd274, and the T lymphocyte chemokine Cxcl9 (Figure 3D).